what a bunch of muppets. They genuinely have no idea what they're talking about - "the more you look into it the more confusing it is". "I'm not an expert in the biotech sector as such". The BP analyst saying IMM is involved in targeting the antibody in auto immune diseases. WTAF?! Didn't even mention that IMM's primary focus is EFTI. And finally had no idea that IMM is about to commence phase 3 trials.
Overnight Market report, page-1337
-
- There are more pages in this discussion • 1,452 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |